Role of the Oral Microbiome in Blood Pressure Regulation in Pregnancy

NCT ID: NCT03930693

Last Updated: 2024-05-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

55 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-06-06

Study Completion Date

2022-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

High blood pressure in pregnancy is associated with poor outcomes for both mum and baby, increasing the risk of pregnancy complications including pre-eclampsia, fetal growth restriction and preterm birth. The development of new blood pressure lowering interventions suitable for use in pregnancy is a key research priority.

Inorganic nitrate is a compound found in certain types of food, particularly green leafy vegetables and beetroot. Nitrate provides an important source of nitric oxide (NO), a molecule involved in keeping blood vessels healthy and regulating blood pressure. Supplementation with nitrate in the diet, using interventions such as beetroot juice, has been shown to reduce blood pressure and improve blood vessel function.

In order for dietary nitrate to have these beneficial effects, it needs to be converted in the body to nitrite, via bacteria that live in the mouth (oral bacteria). Differences in oral bacteria, and how they metabolise nitrate, are thought to influence blood pressure regulation and potentially response to dietary nitrate supplementation.

This study aims to understand (1) whether pregnant women with high blood pressure have a different composition of oral bacteria compared to healthy pregnant women and women who are not pregnant, and (2) how differences in oral bacteria affect blood pressure responses to a dose of dietary nitrate (in the form of beetroot juice).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gestational Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

FACTORIAL

Beetroot juice intervention given to all participants (1 dose only)
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normotensive pregnant women

Normotensive pregnant women

Group Type EXPERIMENTAL

Beetroot juice

Intervention Type DIETARY_SUPPLEMENT

Beetroot juice shot (70mL containing 400mg inorganic nitrate)

Hypertensive pregnant women

Hypertensive pregnant women

Group Type EXPERIMENTAL

Beetroot juice

Intervention Type DIETARY_SUPPLEMENT

Beetroot juice shot (70mL containing 400mg inorganic nitrate)

Normotensive non-pregnant women

Normotensive non-pregnant women

Group Type EXPERIMENTAL

Beetroot juice

Intervention Type DIETARY_SUPPLEMENT

Beetroot juice shot (70mL containing 400mg inorganic nitrate)

Hypertensive non-pregnant women

Hypertensive non-pregnant women

Group Type EXPERIMENTAL

Beetroot juice

Intervention Type DIETARY_SUPPLEMENT

Beetroot juice shot (70mL containing 400mg inorganic nitrate)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Beetroot juice

Beetroot juice shot (70mL containing 400mg inorganic nitrate)

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Normotensive or hypertensive women (hypertension as systolic blood pressure \>140 mmHg and/or diastolic blood pressure \>90 mmHg OR on anti-hypertensive medication)
* For pregnant women, between 20-28 weeks gestation

Exclusion Criteria

* Multi-fetal pregnancy (for pregnant women)
* Age under 16, or over 45 years of age
* Lacking ability to consent
* Pre-existing diabetes (Type 1/Type 2)
* Previous history of pre-term FGR (delivery before 32 weeks with FGR)
* Current tobacco smoker
* Body Mass Index greater than or equal to 40 or less than or equal to 18
* Use of any of the following drugs in the last 6 months: systemic antibiotics, antifungals, antivirals or antiparasitics (intravenous, intramuscular, or oral)
* Large doses of commercial probiotics (greater than or equal to 108 cfu or organisms per day) including tablets, capsules, lozenges, chewing gum or powders (ordinary dietary components such as yoghurts do not apply)
* Evidence of oral disease, assessed on screening proforma (current conditions of: oral candidiasis (thrush); Dental caries (tooth decay); Halitosis; Oral ulcerations/mouth ulcers; Wisdom tooth pain; Chronic dry mouth)
* Allergy to beetroot juice or lemon juice (both contained within the juice shot)
Minimum Eligible Age

16 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Manchester

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr Jenny Myers

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jenny Myers, BM, PhD

Role: PRINCIPAL_INVESTIGATOR

Manchester University NHS Foundation Trust

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Maternal and Fetal Health Research Centre, St Mary's Hospital

Manchester, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Willmott T, Ormesher L, McBain AJ, Humphreys GJ, Myers JE, Singh G, Lundberg JO, Weitzberg E, Nihlen C, Cottrell EC. Altered Oral Nitrate Reduction and Bacterial Profiles in Hypertensive Women Predict Blood Pressure Lowering Following Acute Dietary Nitrate Supplementation. Hypertension. 2023 Nov;80(11):2397-2406. doi: 10.1161/HYPERTENSIONAHA.123.21263. Epub 2023 Sep 13.

Reference Type DERIVED
PMID: 37702047 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

246813

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prenatal Aspirin and Postpartum Vascular Function
NCT05653973 RECRUITING EARLY_PHASE1
The Pregnancy & Early Life Study
NCT03916874 ACTIVE_NOT_RECRUITING